A live attenuated vaccine prevents replication and transmission of H7N9 virus in mammals

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Kong, Huihui ^a   Zhang, Qianyi ^a   Gu, Chunyang ^a,b   Shi, Jianzhong ^a   Deng, Guohua ^a   Ma, Shujie ^a   Liu, Jinxiong ^a   Chen, Pucheng ^a   Guan, Yuntao ^a   Jiang, Yongping ^a   Chen, Hualan ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b China Institute of Veterinary Drug Control   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE;

ANIMAL; IMMUNOLOGY; INFLUENZA A VIRUS (H7N9); PHYSIOLOGY; VIRUS REPLICATION;

ANIMALS; INFLUENZA A VIRUS, H7N9 SUBTYPE; VACCINES, ATTENUATED; VIRUS REPLICATION;

EID: 84931281790     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11233     Document Type: Article

References (34)

1. Subbarao, K. et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279, 393-396 (1998).
2. Peiris, M. et al. Human infection with influenza H9N2. Lancet 354, 916-917 (1999).
3. Tweed, S. A. et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis 10, 2196-2199, doi:10.3201/eid1012.040961 (2004).
4. Gao, R. et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368, 1888-1897, doi:10.1056/NEJMoa1304459 (2013).
5. Yuan, J. et al. Origin and molecular characteristics of a novel 2013 avian influenza A(H6N1) virus causing human infection in Taiwan. Clin. Infect. Dis. 57, 1367-1368, doi:10.1093/cid/cit479 (2013).
6. Chen, H. et al. Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: A descriptive study. Lancet 383, 714-721, doi:10.1016/S0140-6736(14)60111-2 (2014).
7. Shi, J. et al. Isolation and characterization of H7N9 viruses from live poultry markets - Implication of the source of current H7N9 infection in humans. Chin. Sci. Bull. 58, 1857-1863, doi:10.1007/s11434-013-5873-4 (2013).
8. Chen, Y. et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: Clinical analysis and characterisation of viral genome. Lancet 381, 1916-1925, doi:10.1016/S0140-6736(13)60903-4 (2013).
9. Zhang, H. et al. The PB2 E627K mutation contributes to the high polymerase activity and enhanced replication of H7N9 influenza virus. J. Gen. Virol. 95, 779-786, doi:10.1099/vir.0.061721-0 (2014).
10. Mok, C. K. et al. Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts. J. Virol. 88, 3568-3576, doi:10.1128/JVI.02740-13 (2014).
11. Shi, J. et al. Novel influenza A(H7N2) virus in chickens, Jilin province, China, 2014. Emerg Infect Dis 20, 1719-1722, doi:10.3201/eid2010.140869 (2014).
12. Zhang, Q. et al. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science 341, 410-414, doi:10.1126/science.1240532 (2013).
13. Watanabe, T. et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature 501, 551-555, doi:10.1038/nature12392 (2013).
14. Richard, M. et al. Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature 501, 560-563, doi:10.1038/nature12476 (2013).
15. Belser, J. A. et al. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 501, 556-559, doi:10.1038/nature12391 (2013).
16. Zhu, H. et al. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 341, 183-186, doi:10.1126/science.1239844 (2013).
17. Hu, Y. et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. The Lancet 381, 2273-2279, doi:10.1016/s0140-6736(13)61125-3 (2013).
18. Bart, S. A. et al. A cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adults. Sci Transl Med 6, 234ra255, doi:10.1126/scitranslmed.3008761 (2014).
19. Wong, S. S. et al. A single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets. Vaccine 32, 4571-4577, doi:10.1016/j.vaccine.2014.06.016 (2014).
20. Murphy, B. R. & Coelingh, K. Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines. Viral Immunol. 15, 295-323, doi:10.1089/08828240260066242 (2002).
21. Coelingh, K. L., Luke, C. J., Jin, H. & Talaat, K. R. Development of live attenuated influenza vaccines against pandemic influenza strains. Expert Rev Vaccines 13, 855-871, doi:10.1586/14760584.2014.922417 (2014).
22. Chen, H. et al. Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate. Vaccine 21, 4430-4436 (2003).
23. Suguitan, A. L., Jr. et al. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med 3, e360, doi:10.1371/journal.pmed.0030360 (2006).
24. Joseph, T. et al. A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets. Virology 378, 123-132, doi:10.1016/j.virol.2008.05.021 (2008).
25. Chen, Z. et al. Evaluation of live attenuated influenza a virus h6 vaccines in mice and ferrets. J. Virol. 83, 65-72, doi:10.1128/JVI.01775-08 (2009).
26. Fan, S. et al. Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates. PLoS Pathog 5, e1000409, doi:10.1371/journal.ppat.1000409 (2009).
27. Chen, G. L., Lamirande, E. W., Jin, H., Kemble, G. & Subbarao, K. Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets. Virology 398, 109-114, doi:10.1016/j.virol.2009.12.003 (2010).
28. Min, J. Y. et al. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys. J. Virol. 84, 11950-11960, doi:10.1128/JVI.01305-10 (2010).
29. Shi, J. et al. Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice. Antiviral Res. 93, 346-353, doi:10.1016/j.antiviral.2012.01.001 (2012).
30. Chen, Z. et al. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets. J. Virol. 88, 7016-7023, doi:10.1128/JVI.00100-14 (2014).
31. Fodor, E. et al. Rescue of influenza A virus from recombinant DNA. J. Virol. 73, 9679-9682 (1999).
32. Neumann, G. et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci USA 96, 9345-9350 (1999).
33. Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G. & Webster, R. G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 97, 6108-6113, doi:10.1073/pnas.100133697 (2000).
34. Matsuoka, Y. et al. African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates. J. Virol. 88, 8139-8152, doi:10.1128/JVI.00425-14 (2014).